Erythropoietin-Alpha Dosage Requirements in a Provincial Hemodialysis Population: Effect of Switching from Subcutaneous to Intravenous Administration

Publisher： Karger

E-ISSN： 1660-2110|102|3-4|c88-c92

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.102, Iss.3-4, 2005-11, pp. : c88-c92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Change from Subcutaneous to Intravenous Erythropoietin Increases the Cost of Anemia Therapy

By  

Nephron Clin Pract, Vol. 107, Iss. 3, 2007-09 ,pp. : c90-c96

Karger

Access to resources Recommend Favorite

Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 10, 2015-10 ,pp. : 1354-1362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 2151-464X, Iss. 10, 2015-10 ,pp. : 1354-1362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Switching from Epoetin Alpha to Darbepoetin Alpha in Japanese Hemodialysis Patients: Dose Conversion Ratio

By  

Nephron Clin Pract, Vol. 111, Iss. 2, 2008-12 ,pp. : c81-c86

Karger

Access to resources Recommend Favorite

Biocompatibility and Permeability of Dialyzer Membranes Do Not Affect Anemia, Erythropoietin Dosage or Mortality in Japanese Patients on Chronic Non-Reuse Hemodialysis: A Prospective Cohort Study from the J-DOPPS II Study

By  

Nephron Clin Pract, Vol. 109, Iss. 2, 2008-07 ,pp. : c100-c108

Karger

Access to resources Recommend Favorite